Thyroid and cardiovascular system;Schilddrüse und herzkreislaufsystem

Wiener Medizinische Wochenschrift

Volumn 155, Issue 19-20, 2005, Pages 436-443

  Gallowitsch, Hans Jürgen ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Cardiovascular disease; Heart; Hyperthyroidism; Hypothyroidism

Indexed keywords

ERYTHROPOIETIN; THYROID HORMONE;

ARTERIOSCLEROSIS; BLOOD VOLUME; BRADYCARDIA; CARDIOVASCULAR SYSTEM; ERYTHROPOIESIS; HEART AFTERLOAD; HEART LEFT VENTRICLE; HEART PRELOAD; HEART RATE; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE VOLUME; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTEMIC VASCULAR RESISTANCE; THYROID GLAND; TISSUE PERFUSION; VASCULAR SMOOTH MUSCLE; VEIN BLOOD FLOW;

CARDIOVASCULAR SYSTEM; CORONARY ARTERIOSCLEROSIS; HEART; HEMODYNAMIC PROCESSES; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; RISK FACTORS; THYROID FUNCTION TESTS; THYROID GLAND;

EID: 28044466434     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-005-0218-9     Document Type: Review

References (86)

1. Parry CH (1825) Collections from the unpublished papers in the Caleb Hilled Parry. Dis Heart 2: 111-165
2. Rowe GG, Huston JH, Weinstein AB, Tuchman H, Brown JF, Crumpton CW (1956) The hemodynamics of thyrotoxicosis in man with special reference to coronary blood flow and myocardial oxygen metabolism. J Clin Invest 35: 272-276
3. Graettinger JS, Muenster JJ, Selverstone LA, Campbell JA (1959) A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure. J Clin Invest 39: 1316-1327
4. Anthonisen P, Holst E, Thomsen AA (1960) Determination of cardiac output and other hemodynamic data in patients with hyper- and hypothyroidism, using dye dilution technique. Scand J Clin Lab Invest 12: 472-480
5. Abrahmsen AM, Haarstad G, Oulie C (1963) Haemodynamic studies in thyrotoxicosis: before and after treatment. Acta Med Scand 174: 463-467
6. Theilen EO, Wilson WR (1967) Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects. J Appl Physiol 22: 207-210
7. DeGroot WJ, Leonard JJ (1970) Hyperthyroidism as a high cardiac output state. Am Heart J 79: 265-275
8. Lewis BS, Ehrenfeld EN, Lewis N, Gotsman MS (1979) Echocardiographic LV function in thyrotoxicosis. Am Heart J 97: 460-468
9. Merillon JP, Passa P, Chastre J, Wolf A, Gourgon R (1981) Left ventricular function and hyperthyroidism. Br Heart J 46: 137-143
10. Iskandrian AS, Rose L, Hakki AH, Segal BL, Kane SA (1983) Cardiac performance in thyrotoxicosis: analysis of 10 untreated patients. Am J Cardiol 51: 349-352
11. Feldman T, Borow KM, Same DH, Neumann A, Lang RM (1986) Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 7: 967-974
12. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K (1995) Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333: 1562-1563
13. Kahaly GJ, Wagner S, Nieswandt J, Mohr-Kahaly S, Ryan TJ (1999) Stress echocardiography in hyperthyroidism. J Clin Endocrinol Metab 84: 2308-2313
14. Bengel FM, Nekolla SG, Ibrahim T, Weniger C, Ziegler SI, Schwaiger M (2000) Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J Clin Endocrinol Metab 85: 1822-1827
15. von Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R, Beyer J, Meyer J (1989) Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 63: 930-933
16. Sun ZQ, Ojamaa K, Nakamura TY, Artman M, Klein I, Coetzee WA (2001) Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol 33: 811-824
17. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331: 1249-1252
18. Nakazawa H, Sakuri K, Hamada N, Momotani N, Ito K (1982) Management of atrial fibrillation in post-throtoxic state. Am J Med 72: 903-906
19. Klein I, Ojamaa K (1998) Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am 27: 51-62
20. Leak D, Lew M (1962) Effect of treatment of hypothyroidism on circulatory response to adrenaline catecholamine. Br Med J 25: 30-34
21. McDevitt DG, Riddell JG, Hadden DR, Montgomery DA (1978) Catecholamine sensitivity in hyperthyroidism and hypothyroidism. Br J Clin Pharmacol 6: 297-301
22. Bilezikian JP, Loeb JN (1983) The influence of hyperthyroidism and hypothyroidism on- and β-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev 4: 378-388
23. Liggett SB, Shah SD, Cryer PE (1989) Increased fat and skeletal muscle β-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis. J Clin Invest 83: 803-309
24. Levey GS, Klein I (1990) Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88: 642-646
25. Martin III WH, Spina RJ, Korte E (1992) Effect of hyperthyroidism of short duration on cardiac sensitivity to β-adrenergic stimulation. J Am Coll Cardiol 19: 1185-1191
26. Hoit BD, Khoury SF, Shao Y, Gabel M, Liggett SB, Walsh RA (1997) Effects of thyroid hormone on cardiac β-adrenergic responsiveness in conscious baboons. Circulation 96: 592-598
27. Ojamaa K, Klein I, Sabet A, Steinberg SF (2000) Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac β-adrenergic receptor responsiveness. Metabolism 49: 275-279
28. Cacciatori V, Bellavere F, Pezzarossa A, Dellera A, Gemma ML, Thomaseth K, Castello R, Moghetti P, Muggeo M (1996) Power spectral analysis of heart rate in hyperthyroidism. J Clin Endocrinol Metab 81: 2828-2835
29. Gibson JG, Harris AW (1939) Clinical studies on the blood volume: V Hyperthyroidism and myxedema. J Clin Invest 18: 59-65
30. Resnick LM, Laragh JH (1982) Plasma renin activity in syndromes of thyroid hormone excess and deficiency. Life Sci 30: 585-586
31. Klein I, Levey GS (1984) Unusual manifestations of hypothyroidism. Arch Intern Med 144: 123-128
32. Nixon JV, Anderson RJ, Cohen ML (1979) Alterations in left ventricular mass and performance in patients treated effectively for thyrotoxicosis. A comparative echocardiographic study. Am J Med 67: 268-276
33. Cohen MV, Schulman IC, Spenillo A, Surks MI (1981) Effects of thyroid hormone on left ventricular function in patients treated for thyrotoxicosis. Am J Cardiol 48: 33-38
34. Friedman MJ, Okada RD, Ewy GA, Hellman DJ (1982) Left ventricular systolic and diastolic function in hyperthyroidism. Am Heart J 104: 1303-1308
35. Forfar JC, Matthews DM, Toft AD (1984) Delayed recovery of left ventricular function after antithyroid treatment. Further evidence for reversible abnormalities of contractility in hyperthyroidism. Br Heart J 52: 215-222
36. Mintz G, Pizzarello R, Klein I (1991) Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. J Clin Endocrinol Metab 73: 146-150
37. Nakatani S, Beppu S, Nagata S, Ishikura F, Tamai J, Yamagishi M, Ohmori F, Kimura K, Takamiya M, Miyatake K (1994) Diastolic suction in the human ventricle: observation during balloon mitral valvuloplasty with a single balloon. Am Heart J 127: 143-147
38. Udelson JE, Bacharach SL, Cannon RO III, Bonow RO (1990) Minimum left ventricular pressure during β-adrenergic stimulation in human subjects. Evidence for elastic recoil and diastolic "suction" in the normal heart. Circulation 82: 1174-1182
39. Rothfeld JM, LeWinter MM, Tishler MD (1998) Left ventricular systolic torsion and early diastolic filling by echocardiography in normal humans. Am J Cardiol 81: 1465-1469
40. Ojamaa K, Klemperer JD, Klein I (1996) Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6: 505-512
41. Grossman W, Robin NI, Johnson LW, Brooks HL, Selenkow HA, Dexter L (1971) The enhanced myocardial contractility of thyrotoxicosis. Role of the β adrenergic receptor. Ann Intern Med 74: 869-874
42. Streeten DH, Anderson GH Jr, Howland T, Chiang R, Smulyan H (1988) Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11: 78-83
43. Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 87: 968-974
44. Klein I, Hong C (1986) Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest 77: 1694-1698
45. Sugden PH, Clerk A (1998) Cellular mechanisms of cardiac hypertrophy. J Mol Med 76: 725-746
46. Coleman PS, Parmacek MS, Lesch M, Samarel AM (1989) Protein synthesis and degradation during regression of thyroxine-induced cardiac hypertrophy. J Mol Cell Cardiol 21: 911-925
47. Klein I (1990) Thyroid hormone and blood pressure regulation. In: Laragh J, Brenner B (eds) Hypertension. Raven Press, New York, pp 1661-1674
48. Klein I (1988) Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol. Endocrinology 123: 203-210
49. Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard MC, Gammage MD (1996) Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart 75: 363-368
50. Shapiro LE, Sievert R, Ong L, Ocampo EL, Chance RA, Lee M, et al. (1997) Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. J Clin Endocrinol Metab 82: 2592-2595
51. Biondi B, Fazio S, Carella C, Amato G, Cittadini A, Lupoli G, et al. (1993) Cardiac effects of long term thyrotropin-suppressive therapy with levo-thyroxine. J Clin Endocrinol Metab 77: 334-338
52. Jennings PE, O'Malley BP, Griffin KE, Northover B, Rosenthal FD (1984) Relevance of increased serum thyroxine concentrations associated with normal serum tri-iodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis". Br Med J (Clin Res Ed) 289: 1645-1647
53. Bell GM, Sawers JS, Forfar JC, Doig A, Toft AD (1983) The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion. Clin Endocrinol (Oxf) 18: 511-516
54. Biondi B, Fazio S, Carella C, Sabatini D, Amato G, Cittadini A, et al. (1994) Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levo-thyroxine. J Clin Endocrinol Metab 78: 1028-1033
55. Biondi B, Fazio S, Cuocolo A, Sabatini D, Nicolai E, Lombardi G, et al. (1996) Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levo-thyroxine. J Clin Endocrinol Metab 81: 4224-4228
56. Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, et al. (2000) Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levo-thyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 85: 159-164
57. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331: 1249-1252
58. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, et al. (2000) Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 85: 4701-4705
59. Klein I (2004) The cardiovascular system in hypothyroidism. In: Braverman L, Utiger R (eds) Werner & Ingbar's. The thyroid: a fundamental and clinical text. 9th ed. Lippincott Williams & Wilkins, Philadelphia
60. Brent GA (1994) The molecular basis of thyroid hormone action. N Engl J Med 331: 847-854
61. Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 87: 968-974
62. Weishammer S, Keck FS, Waitzinger J, Henze E, Loos U, Hombach V, et al. (1989) Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. Can J Physiol Pharmacol 67: 1007-1010
63. Diekman T, Demacker PN, Kastelein JJ, Stalenhoef AF, Wiersinga WM (1998) Increased oxidizability of low-density lipoproteins in hypothyroidism. J clin Endocrinol metab 83: 1752-1755
64. Kung AW, Pang RW, Janus ED (1995) Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endrocrinol (Oxf) 43: 445-449
65. Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH (2001) Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nurtrition Examination Survey. Atherosclerosis 155: 195-200
66. Cappola AR, Ladenson PW (2003) Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88: 2438-2444
67. Biondi B, Klein I (2004) Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24: 1-13
68. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC (1984) L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med 101: 18-24
69. Danese MD, Ladenson PW, Meinert CI, Powe NR (2000) Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 85: 2993-3001
70. Bough EW, Crowley WF, Ridgway C, Walker H, Maloof F, Myers GS, et al. (1978) Myocardial function in hypothyroidism. Relation to disease severity and response to treatment. Arch Intern Med 138: 1476-1480
71. Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, et al. (1992) Spectrum of subclinical and overt hypothyroisism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 92: 631-642
72. Ridgway EC, Cooper DS, Walker H, Rodbard D, Maloof F (1981) Peripheral responses to thyroid hormone before and after 1-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 53: 1238-1242
73. Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, et al. (1999) Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 84: 2064
74. Di Bello V, Monzani F, Giorgi D, Bertini A, Caraccio N, Valenti G, et al. (2000) Ultrasonic myocardial textural analysis in subclinical hypothyroidism. J Am Soc Echocardiogr 13: 832-840
75. Kahaly GJ (2000) Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10: 665-679
76. Forfar JC, Wathen CG, Todd WT, Bell GM, Hannan WJ, Muir AL, et al. (1985) Left ventricular performance in subclinical hypothyroidism. Q J Med 57: 857-865
77. Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JC (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132: 270
78. Bauer DC, Ettinger B, Browner WS (1998) Thyroid functions and serum lipids in older women: a population-based study. Am J Med 104: 546-551
79. Danese MD, Ladenson PW, Meinert CI, Powe NR (2000) Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 85: 2993-3001
80. Caraccio N, Ferrannini E, Monzani F (2002) Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 87: 1533-1538
81. Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ, Ozden M (2003) Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Endocr Res 29: 307-316
82. Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C, et al. (2001) Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 86: 1110
83. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. (2003) Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88: 3731-3737
84. Lekakis J, Papamichael C, Alevizaki M, Piperinges G, Marafelia P, Mantzos J, et al. (1997) Flow-mediated endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7: 411-414
85. Lindeman RD, Romero LJ, Schade DS, Wayne S, Baumgartner RN, Carry PJ (2003) Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey. Thyroid 13: 595-600
86. Perk M, O'Neill BJ (1997) The effect of thyroid hormone therapy on angiographic coronary aartery disease progression. Can J Cardiol 13: 273-276